Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quadruple eradication regimens for penicillin-allergic patients with Helicobacter pylori infection
ChiCTR1900023702Phase 4Not yet recruiting
- Sponsor
- Peking University Third Hospital
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of cefuroxime, minocycline and metronidazole in Helicobacter pylori infection (3 arms), sponsored by Peking University Third Hospital. Primary endpoint: Eradication rate. Planned start Jun 2019; status: not yet recruiting.
02
Drugs
cefuroximeminocyclinemetronidazole
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on ChiCTR1900023702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900023702.